Key result
Metabolic syndrome incidence reaches ~5% over 3.6 years in Tehranian adolescents.
Cohort (n=932)
OBJECTIVE: To assess the incidence and trend of the metabolic syndrome phenotype in adolescents from the Tehran Lipid and Glucose Study during 3.6 years of follow-up. RESEARCH DESIGN AND METHODS: A total of 932 adolescents, aged 10-19 years, who had complete data and returned for reassessment 3.6 years later were investigated. RESULTS: Prevalence of metabolic syndrome at baseline and after 3.6 years was 7.4 and 6.7%, respectively, based on the Adult Treatment Panel (ATP) III definitions; 3.5 and 8.0%, respectively, based on the International Diabetes Federation (IDF) definitions; 4.1 and 9.4%, respectively, based on the American Heart Association (AHA) definitions; and 13.6 and 13.4%, respectively, based on the National Health and Nutrition Examination Survey (NHANES) definitions. Incidence rates were 5.2% (95% CI 3-6) based on ATP III, 6.8% (5-8) based on IDF, 8.3% (6-10) based on AHA, and 8.8% (6-10) based on NHANES definitions. CONCLUSIONS: Incidence of metabolic syndrome is high in Tehranian adolescents.
No takes yet. Share an insight, caveat, or question.
Afkhami‐Ardekani et al. (2010) conducted a cohort in Metabolic syndrome phenotype (n=932). Metabolic syndrome criteria (ATP III, IDF, AHA, NHANES) was evaluated on Incidence of metabolic syndrome (95% CI 3-6). Tehranian adolescents had a 3.6-year metabolic syndrome incidence of 5.2% (ATP III), 6.8% (IDF), 8.3% (AHA), and 8.8% (NHANES).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: